
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
Out-licensing
Zealand aims to establish partnerships with major pharmaceutical companies after having established “proof-of-concept”, or earlier if such partnership will advance the development of Zealand Pharma’s development candidates.
Contact person:
Arvind M. Hundal
Director of Business Development
Phone: +45 43 28 12 46
e-mail: amh@zp.dk
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010